Response to Stacey and Moller's letter to the Editor

摘要

We appreciate the authors' interest in the study and belief that rigorous studies are needed to address the potential role, or not, of cannabinoids in pain research, particularly in the area of neuropathic pain, where upwards of 40-60% of patients fail to get relief from current treatments.4 We agree that much is still unknown regarding the potential use of cannabis as medicine, such as How frequently would it need to be administered? Is any benefit sustainable? What are the short- and long-term effects on daily functioning (positive and negative)? What is the therapeutic window?